US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period. Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025. North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet. The global Orally Disintegrating Tablets market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Orally Disintegrating Tablets volume and value at global level, regional level and company level. From a global perspective, this report represents overall Orally Disintegrating Tablets market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Teva Merck Mylan Pfizer Johnson and Johnson GSK Otsuka Eli Lilly and Company AstraZeneca Bristol-Myers Squibb Conquer Segment by Regions North America Europe China Japan Segment by Type Anti-Psychotics Drug Anti-Epileptics Drug Other Segment by Application CNS Diseases Gastrointestinal Diseases CVS Diseases Other
Table of Contents Executive Summary 1 Orally Disintegrating Tablets Market Overview 1.1 Product Overview and Scope of Orally Disintegrating Tablets 1.2 Orally Disintegrating Tablets Segment by Type 1.2.1 Global Orally Disintegrating Tablets Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Anti-Psychotics Drug 1.2.3 Anti-Epileptics Drug 1.2.4 Other 1.3 Orally Disintegrating Tablets Segment by Application 1.3.1 Orally Disintegrating Tablets Consumption Comparison by Application (2014-2025) 1.3.2 CNS Diseases 1.3.3 Gastrointestinal Diseases 1.3.4 CVS Diseases 1.3.5 Other 1.4 Global Orally Disintegrating Tablets Market by Region 1.4.1 Global Orally Disintegrating Tablets Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Orally Disintegrating Tablets Market Size 1.5.1 Global Orally Disintegrating Tablets Revenue (2014-2025) 1.5.2 Global Orally Disintegrating Tablets Production (2014-2025) 2 Global Orally Disintegrating Tablets Market Competition by Manufacturers 2.1 Global Orally Disintegrating Tablets Production Market Share by Manufacturers (2014-2019) 2.2 Global Orally Disintegrating Tablets Revenue Share by Manufacturers (2014-2019) 2.3 Global Orally Disintegrating Tablets Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Orally Disintegrating Tablets Production Sites, Area Served, Product Types 2.5 Orally Disintegrating Tablets Market Competitive Situation and Trends 2.5.1 Orally Disintegrating Tablets Market Concentration Rate 2.5.2 Orally Disintegrating Tablets Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Orally Disintegrating Tablets Production Market Share by Regions 3.1 Global Orally Disintegrating Tablets Production Market Share by Regions 3.2 Global Orally Disintegrating Tablets Revenue Market Share by Regions (2014-2019) 3.3 Global Orally Disintegrating Tablets Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Orally Disintegrating Tablets Production 3.4.1 ... | read more...